Clinical trials
Terminated Phase 2 Immunoblastic Lymphadenopathy trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Northside Hospital, Inc. | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Fondazione Italiana Linfomi - ETS | 1 |
| Fred Hutchinson Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute (NCI) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoblastic Lymphadenopathy | 9 |
| Lymphoma, Large-Cell, Anaplastic | 6 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Lymphoma | 5 |
| Lymphoma, B-Cell, Marginal Zone | 5 |
| Lymphoma, Follicular | 5 |
| Waldenstrom Macroglobulinemia | 5 |
| Leukemia, Prolymphocytic | 4 |
| Lymphoma, Extranodal NK-T-Cell | 4 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.